R&D
Our state-of-the-art 50,000 sq.ft. R&D center supports the full spectrum of vaccine development—from pre-clinical studies to product licensure. The facility houses specialized laboratories for molecular biology, immunology, fermentation, purification, cell culture, hybridoma technology, and virus handling, making it ideally equipped for advanced vaccine and biologics research. The R&D center is further supported by a scientific library, lecture hall, centralized monitoring systems, and all essential utilities—creating a fully integrated and modern research environment.
Our R&D team is currently focused on developing vaccines and biologics for high-priority public health needs, We also collaborate with academic institutions to support advanced training and encourage Ph.D. research among our employees.
At GCBC, we believe strongly that collaboration with national and international organizations is key to advancing vaccine innovation and accelerating the path from research to commercialization. These strategic partnerships play a vital role in ensuring that safe, effective, and affordable vaccines reach those who need them most across the globe.
Research & Development
GCBC Vaccines is a research-driven organization that invests into R&D to address critical global health challenges. Backed by strong scientific partnerships and a highly skilled team, our R&D efforts uphold the highest standards of scientific integrity, end-to-end development excellence, and robust pharmacovigilance.
